Side-by-side comparison of AI visibility scores, market position, and capabilities
London D2C e-commerce OS (founded 2022); $40M ICONIQ Growth Series B (March 2025) after 7x revenue growth with Importer of Record model serving 500+ fashion brands ($20M-$100M) competing with Global-e for cross-border operations.
Swap is a London, United Kingdom-based e-commerce operating system for direct-to-consumer brands — backed with approximately $49 million in total funding including a $40 million Series B in March 2025 led by ICONIQ Growth with Cherry Ventures, QED Investors, and 9900 Capital — providing a unified platform for cross-border logistics, inventory management, and international operations that reduces operational costs by up to 30% and improves revenue by 8% for 500+ fashion, eyewear, and lifestyle brands. Founded in 2022 by CEO Sam Atkinson and CPO Zach Bailet (whose direct experience running a cross-border e-commerce business sourcing from Africa informed the platform's design), Swap achieved 7x revenue growth between March 2024 and March 2025. Brands including 3.1 Phillip Lim, Sandy Liang, Ed Hardy, Pangaia, The Frankie Shop, and Odd Muse (typically $20M-$100M annual sales) rely on Swap for Importer of Record services, delivered duty paid (DDP) shipping, automated tax remittance, and express customs clearance across 190+ countries. Swap Inventory (AI-powered demand forecasting and smart restocking) launched in 2025 alongside expansion to Australia and Canada.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.